Career
front-page.php
90%
profits
reinvest
reinvest
+20%
targets growth
annually
annually
20+
new products
annually
annually
600+
registration
certificates
certificates
41+
operate in countries
around the world
around the world
25%
is part of the
exports
exports
War in Ukraine
Year of war in Ukraine
Last year for us, like all Ukrainians, was a daily test for stability and loyalty to a common idea. We each received a unique experience of restructuring processes and organizing work in new realities. From the very first days of the full-scale invasion, we began to resume manufacturing activities. Logistics is the most critical issue…
War in Ukraine
Test for resilience under energy deficiency
After massive missile strikes that destroyed critical infrastructure, we faced the need to reduce electricity consumption in order to save power in the unified energy system of Ukraine. At the same time, it was critically important for us to release the planned volume of products. We were preparing for different scenarios, the starting point for…
About the company
July 9 is the anniversary of the founding of YURiA-PHARM
July 9 is the anniversary of the founding of the Ukrainian pharmaceutical group YURіA-PHARM. It was thirty-two years ago that the business was founded, which grew, developed and changed together with Ukraine. During this time, we have experienced many trials, but we have never had to work during a war. War. In the early days,…
War in Ukraine
February 24, 2022 Сhronicle of the war
The war mobilized and rallied domestic pharmaceutical companies to selfless work 24/7. We all understand what an important duty is entrusted to us: to support the defense capability of our country, providing the health care system and military medicine with the necessary medicines. Today, YURіА-PHARM has focused on two directions – production and distribution. Production….
Key areas of R&D
- Adaptation, development and scaling of technologies for the production of biopharmaceutical APIs and drugs based on them
- Development of products based on hyaluronic acid
- Development of Active Pharmaceutical Ingredients
- Development and implementation in manufacturing of hospital drugs and medical devices
Products
Umerox® Ingal
Umerox® Ingal is an individual device designed for inhalation of methoxyflurane. Methoxyflurane, solution for inhalation, 2 ml administered through the Yumerox® Ingal inhaler is a fast-acting, inhalable and non-narcotic analgesic. Indications for the use of Methoxyflurane are emergency relief of moderate to severe pain in adult patients with trauma who are conscious. Аnesthesia for short-term treatment…
Learn more
